Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
President Barack Obama signed the Drug Quality and Security Act into law last Wednesday, encouraging healthcare providers to purchase compounded drugs from federally regulated facilities.
Mundelein, Ill.-based Medline Industries is planning to build a new facility in Chesterfield, Va., to replace the current distribution center, according to a report by The Richmond Times-Dispatch.
Abbott Park, Ill.-based Abbott has issued a nationwide recall of 20 lots of FreeStyle and FreeStyle Lite Blood Glucose Test Strips, according to a news release.
BioMedical Enterprises has received clearance from the U.S. Food and Drug Administration on an upgrade to its patent-pending Hammerlock Intramedullary Fixation System for hammertoe deformities, according to a news release.
Cary, N.C.-based Myco Medical has won a private-label contract deal with Novation, according to a Triangle Business Journal report.
The global market for medical transcription services is expected to reach $60.6 million by 2019, according to a news release from Transparency Market Research.
The U.S. Food and Drug Administration has issued a Class I Recall on Spacelabs Healthcare's BleaseSirius and BleaseFocus Anesthesia Workstations due to loose hardware in the CAS I/II Absorbers, which could cause the Bag-to-Vent switch to fail.
Pomona, Calif.-based CLR Medicals International has issued a nationwide recall on its Viscocel and Viscocel Plus products.
Janssen Therapeutics, a division of Janssen Products, announced that the U.S. Food and Drug Administration approved OLYSIO (simeprevir), an NS3/4A protease inhibitor.
The U.S. Food and Drug Administration issued a warning letter to 23andMe to stop marketing and selling the company's Saliva Collection Kit and Personal Genome Service, saying the PGS had not received approval from the FDA.